Loading clinical trials...

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 3NCT05028569

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound (International Classification of Headache Disor...

Lead sponsor: AbbVie•82 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

RECRUITING

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

RECRUITING

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

RECRUITINGNA

The RECLAIM Study.

NCT06450444 · Chronic Migraine, High Frequency Episodic Migraine

RECRUITINGPhase 2

Efficacy of Nerve Blocks for Episodic Migraine

NCT05734625 · Episodic Migraine

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2025Terms

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment775

Start dateNov 2021

Last updatedDec 9, 2025

Condition

Episodic Migraine

Locations shown

Neurology and Neurodiagnostics of Alabama /ID# 231918

Hoover, Alabama

Rehabilitation & Neurological Services /ID# 252441

Huntsville, Alabama

Alea Research /ID# 233329

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions